Pramipexole in patients with early Parkinson's disease

Clinical Neuropharmacology

Volumn 18, Issue 4, 1995, Pages 338-347

  Hubble, J P ^a   Koller, W C ^a   Cutler, N R ^a   Sramek, J J ^a   Friedman, J ^a   Goetz, C ^a   Ranhosky, A ^a   Korts, D ^a   Elvin, A ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Dopamine agonist; Parkinson's disease; Pramipexole

Indexed keywords

DOPAMINE 2 RECEPTOR STIMULATING AGENT; PLACEBO; PRAMIPEXOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERANCE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO; XEROSTOMIA;

EID: 0029087376     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199508000-00006     Document Type: Article

References (0)